Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Johnson

Showing results (131-140 of 221) with videos related to

Pageof 23
Sort By:
The American Journal of Medicine|August 27, 2018
Applying the 'COST' (Culture, Oversight, Systems Change, and Training) Framework to De-Adopt the Neutropenic DietArjun Gupta, Timothy J Brown, Shruti Singh, et al.
Plos One|September 17, 2016
Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart StudyArjun Gupta, Yehuda Herman, Colby Ayers, et al.
Journal of Clinical Epidemiology|February 28, 2002
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592David Cella, David T Eton, Diane L Fairclough, et al.
Digestive Diseases and Sciences|March 25, 2018
Tropheryma whipplei Infection (Whipple Disease) in the USAIsabel A Hujoel, David H Johnson, Benjamin Lebwohl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancerSarita Dubey, Patricia Stephenson, Donna E Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysisArjun Gupta, Kaustav Majumder, Nivedita Arora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group studySeena C Aisner, Suzanne Dahlberg, Meera R Hameed, et al.
The Oncologist|March 15, 2013
Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studiesHerbert I Hurwitz, Pamela S Douglas, John P Middleton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the Eastern Cooperative Oncology Group 4599 Study: results of an exploratory analysisAriel Lopez-Chavez, Todd Young, Sophie Fages, et al.
Pageof 23

Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
The American Journal of Medicine|August 27, 2018
Applying the 'COST' (Culture, Oversight, Systems Change, and Training) Framework to De-Adopt the Neutropenic DietArjun Gupta, Timothy J Brown, Shruti Singh, et al.
Plos One|September 17, 2016
Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart StudyArjun Gupta, Yehuda Herman, Colby Ayers, et al.
Journal of Clinical Epidemiology|February 28, 2002
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592David Cella, David T Eton, Diane L Fairclough, et al.
Digestive Diseases and Sciences|March 25, 2018
Tropheryma whipplei Infection (Whipple Disease) in the USAIsabel A Hujoel, David H Johnson, Benjamin Lebwohl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancerSarita Dubey, Patricia Stephenson, Donna E Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysisArjun Gupta, Kaustav Majumder, Nivedita Arora, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperative Oncology Group studySeena C Aisner, Suzanne Dahlberg, Meera R Hameed, et al.
The Oncologist|March 15, 2013
Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studiesHerbert I Hurwitz, Pamela S Douglas, John P Middleton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Bevacizumab maintenance in patients with advanced non-small-cell lung cancer, clinical patterns, and outcomes in the Eastern Cooperative Oncology Group 4599 Study: results of an exploratory analysisAriel Lopez-Chavez, Todd Young, Sophie Fages, et al.
Pageof 23